COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report
and promotion of well-being
Epidemiology
Logistic regression
32 Biomedical and Clinical Sciences
Infectious disease (medical specialty)
FOS: Health sciences
Immunization; Immunodeficiency; Outcomes; Viruses: respiratory diseases
Pediatrics
Disease
3202 Clinical Sciences
Internal medicine
Outcome
Pediatric
Immunology and Microbiology
Vaccines
0303 health sciences
Vaccination
Life Sciences
3 Good Health and Well Being
3204 Immunology
Hospitalization
Infectious Diseases
3.4 Vaccines
1107 Immunology
Medicine
Emergency medicine
Original Article
Infection
COVID-19 Vaccines
Critical Care
Immunology
610
Outcomes
Coronavirus Disease 2019 Research
Vaccine Related
03 medical and health sciences
Clinical Research
Biodefense
Health Sciences
Epidemiology and Pathogenesis of Respiratory Viral Infections
Immunodeficiency
Humans
3 Prevention of disease and conditions
Prevention
Genetic Basis of Primary Immunodeficiency Disorders
FOS: Clinical medicine
Immunity
COVID-19
Viruses: respiratory diseases
Coronavirus disease 2019 (COVID-19)
Emerging Infectious Diseases
Immunization
DOI:
10.1007/s10875-023-01613-5
Publication Date:
2024-04-05T05:01:46Z
AUTHORS (158)
ABSTRACT
Abstract Background The CDC and ACIP recommend COVID-19 vaccination for patients with inborn errors of immunity (IEI). Not much is known about vaccine safety in IEI, whether attenuates infection severity IEI. Objective To estimate examine effect on outcomes Methods We built a secure registry database conjunction the US Immunodeficiency Network to frequency indicators effectiveness IEI patients. opened January 1, 2022, closed August 19, 2022. Results Physicians entered data 1245 from 24 countries. most common diagnoses were antibody deficiencies (63.7%). At least one was administered 806 (64.7%), 216 received prior development COVID-19. vaccines mRNA-based (84.0%). Seventeen reported seek outpatient clinic or emergency room care vaccine-related complication, patient hospitalized symptomatic anemia. Eight hundred twenty-three (66.1%) experienced infection. Of these, 156 required hospitalization (19.0%), 47 ICU (5.7%), 28 died (3.4%). Rates (9.3% versus 24.4%, p < 0.001), admission (2.8% 7.6%, = 0.013), death (2.3% 4.3%, 0.202) who had lower In adjusted logistic regression analysis, not having at significantly increased odds admission. Conclusion Vaccination population appears safe severity.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (5)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....